Mr. Wanstok, has been serving as the president of MicroPort Cardiac Rhythm Management Limited (微創心律管理有限公司) (“CRM”) since November 2024. He joined CRM in November 2017 as vice president of global sales and served as the first vice president of global sales and marketing of CRM from September 2019 to November 2024. Mr. Wanstok has over 36 years of experience in the medical devices industry. Prior to joining CRM, from 1988 to 1995, Mr. Wanstok worked at Medtronic plc, a medical devices and medical technology company offering therapies for different health conditions (including cardiac rhythm management) whose shares are listed on the New York Stock Exchange (symbol: MDT). From 1995 to 1998, Mr. Wanstok worked at InControl Inc. (“InControl”), a company designing and developing medical devices aiming at treating Atrial Fibrillation as General Manager South Europe. InControl was acquired by Guidant Corporation in 1998. From 1998 to 2006, Mr. Wanstok worked at Guidant Corporation, a company principally engaged in the design and manufacturing of cardiovascular medical products with different roles including EMEA CRM marketing director and general manager of Spain. From 2006 to 2009, Mr. Wanstok worked at Boston Scientific Corporation, a medical devices company whose shares are listed on the New York Stock Exchange (symbol: BSX), where he was primarily responsible for establishing and launching marketing strategies for all international geographies. From 2009 to 2012, Mr. Wanstok returned to Medtronic plc as CRM Internation General Manager. From July 2012 to May 2017, he served as the chief commercial officer at CVRx Inc., a company engaged in the development and manufacturing of medical devices aiming at treating Heart Failure, whose shares are listed on the NASDAQ (symbol: CVRX).

Mr. Wanstok graduated from Paris University (Paris I-La Sorbonne) in France in June 1990, and completed a DESS in foreign trade, a diploma which is only accessible after obtaining a master’s degree, in October 1989 with a major in economics.